263 related articles for article (PubMed ID: 15156190)
21. Runx3-/- gastric epithelial cells differentiate into intestinal type cells.
Fukamachi H; Ito K; Ito Y
Biochem Biophys Res Commun; 2004 Aug; 321(1):58-64. PubMed ID: 15358215
[TBL] [Abstract][Full Text] [Related]
22. Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines.
Ku JL; Kang SB; Shin YK; Kang HC; Hong SH; Kim IJ; Shin JH; Han IO; Park JG
Oncogene; 2004 Sep; 23(40):6736-42. PubMed ID: 15273736
[TBL] [Abstract][Full Text] [Related]
23. Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma.
Osaki M; Moriyama M; Adachi K; Nakada C; Takeda A; Inoue Y; Adachi H; Sato K; Oshimura M; Ito H
Eur J Clin Invest; 2004 Sep; 34(9):605-12. PubMed ID: 15379759
[TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer.
Kitajima Y; Ohtaka K; Mitsuno M; Tanaka M; Sato S; Nakafusa Y; Miyazaki K
Oncol Rep; 2008 Jan; 19(1):197-202. PubMed ID: 18097595
[TBL] [Abstract][Full Text] [Related]
25. Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer.
Sakakura C; Hagiwara A; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ito K; Yamagishi H; Yazumi S; Chiba T; Ito Y
Int J Cancer; 2005 Jan; 113(2):221-8. PubMed ID: 15386419
[TBL] [Abstract][Full Text] [Related]
26. Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines.
Yanada M; Yaoi T; Shimada J; Sakakura C; Nishimura M; Ito K; Terauchi K; Nishiyama K; Itoh K; Fushiki S
Oncol Rep; 2005 Oct; 14(4):817-22. PubMed ID: 16142337
[TBL] [Abstract][Full Text] [Related]
27. Exclusion of RUNX3 as a tumour-suppressor gene in early-onset gastric carcinomas.
Carvalho R; Milne AN; Polak M; Corver WE; Offerhaus GJ; Weterman MA
Oncogene; 2005 Dec; 24(56):8252-8. PubMed ID: 16091737
[TBL] [Abstract][Full Text] [Related]
28. An enigmatic fourth runt domain gene in the fugu genome: ancestral gene loss versus accelerated evolution.
Glusman G; Kaur A; Hood L; Rowen L
BMC Evol Biol; 2004 Nov; 4():43. PubMed ID: 15527507
[TBL] [Abstract][Full Text] [Related]
29. Cancer: new-age tumour suppressors.
Balmain A
Nature; 2002 May; 417(6886):235-7. PubMed ID: 12015584
[No Abstract] [Full Text] [Related]
30. MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer.
Lai KW; Koh KX; Loh M; Tada K; Subramaniam MM; Lim XY; Vaithilingam A; Salto-Tellez M; Iacopetta B; Ito Y; Soong R;
Eur J Cancer; 2010 May; 46(8):1456-63. PubMed ID: 20176475
[TBL] [Abstract][Full Text] [Related]
31. Loss of RUNX3 expression correlates with differentiation, nodal metastasis, and poor prognosis of gastric cancer.
Hsu PI; Hsieh HL; Lee J; Lin LF; Chen HC; Lu PJ; Hsiao M
Ann Surg Oncol; 2009 Jun; 16(6):1686-94. PubMed ID: 19290488
[TBL] [Abstract][Full Text] [Related]
32. Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis.
Wei D; Gong W; Oh SC; Li Q; Kim WD; Wang L; Le X; Yao J; Wu TT; Huang S; Xie K
Cancer Res; 2005 Jun; 65(11):4809-16. PubMed ID: 15930301
[TBL] [Abstract][Full Text] [Related]
33. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis.
Yano T; Ito K; Fukamachi H; Chi XZ; Wee HJ; Inoue K; Ida H; Bouillet P; Strasser A; Bae SC; Ito Y
Mol Cell Biol; 2006 Jun; 26(12):4474-88. PubMed ID: 16738314
[TBL] [Abstract][Full Text] [Related]
34. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
35. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic inactivation of the RUNX3 gene in lung cancer.
Sato K; Tomizawa Y; Iijima H; Saito R; Ishizuka T; Nakajima T; Mori M
Oncol Rep; 2006 Jan; 15(1):129-35. PubMed ID: 16328045
[TBL] [Abstract][Full Text] [Related]
37. RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer.
Peng Z; Wei D; Wang L; Tang H; Zhang J; Le X; Jia Z; Li Q; Xie K
Clin Cancer Res; 2006 Nov; 12(21):6386-94. PubMed ID: 17085650
[TBL] [Abstract][Full Text] [Related]
38. RUNX: a trilogy of cancer genes.
Lund AH; van Lohuizen M
Cancer Cell; 2002 Apr; 1(3):213-5. PubMed ID: 12086855
[TBL] [Abstract][Full Text] [Related]
39. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
Mori T; Nomoto S; Koshikawa K; Fujii T; Sakai M; Nishikawa Y; Inoue S; Takeda S; Kaneko T; Nakao A
Liver Int; 2005 Apr; 25(2):380-8. PubMed ID: 15780064
[TBL] [Abstract][Full Text] [Related]
40. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.
Kim WJ; Kim EJ; Jeong P; Quan C; Kim J; Li QL; Yang JO; Ito Y; Bae SC
Cancer Res; 2005 Oct; 65(20):9347-54. PubMed ID: 16230397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]